title: Tumour necrosis factor-alpha antagonists in the management of rheumatoid arthritis in the elderly: a review of their efficacy and safety.
abstract: Rheumatoid arthritis (RA) is a chronic inflammatory disease that frequently affects people aged >or=65 years, causing significant impairment with pain and functional disability. Elderly RA patients have specific problems, including co-morbid diseases, numerous concomitant medications, greater number of damaged joints as a result of longer disease duration and often a more severe disease presentation in elderly-onset RA. These factors, together with an age-related decline in the immune defence mechanisms, make elderly patients more vulnerable. The new era of biologic medications has made intensive treatment of RA patients possible. Anti-tumour necrosis factor-alpha (anti-TNFalpha) agents can cause a dramatic improvement in disease activity and functional capacity, making complete remission of RA a possible target. TNFalpha has been shown to play an important role in both the healthy aging process and age-related diseases such as RA. Targeting this cytokine in elderly patients is therefore reasonable. However, it is not clear whether treatment effects can be reached to the same extent in both elderly and younger patients and whether anti-TNFalpha treatment specifically increases the risk of certain adverse events in elderly RA patients. This review discusses the currently available evidence relating to the efficacy and safety of anti-TNFalpha medication in RA patients aged >or=65 years treated in clinical trials and observational studies. Despite a slightly less robust effect in elderly patients, anti-TNFalpha treatment has a similar long-term efficacy in patients aged >or=65 years and patients aged <65 years. The majority of the study results showed that anti-TNFalpha treatment does not elevate the risk of infections beyond the risk found in age-matched controls. When a moderate increase in risk was found, this occurred equally in elderly and younger patients. Furthermore, whereas anti-TNFalpha agents were found to be relatively safe in the treatment of elderly RA patients, treatment with corticosteroids significantly elevated the risk of serious infections. Corticosteroids are frequently used in elderly patients, but the evidence suggests that preference should increasingly be given to anti-TNFalpha agents, for which the expected benefits will mostly outweigh the modestly increased risks of associated adverse events.
authors.affiliation: Department of Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, the Netherlands.
authors.forename: Beáta J
authors.initials: BJ
authors.lastname: Radovits
authors.forename: Wietske
authors.initials: W
authors.lastname: Kievit
authors.forename: Roland F J M
authors.initials: RF
authors.lastname: Laan
mesh_terms: D000368:Aged; D000375:Aging / Q000276:immunology; D000818:Animals; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology / Q000628:therapy; D006801:Humans; D016896:Treatment Outcome; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha
references.citation: Br J Rheumatol. 1998 Apr;37(4):459-60
references.pmid: 9619900
references.citation: Autoimmun Rev. 2009 Jan;8(3):266-73
references.pmid: 19022409
references.citation: Endocr J. 1999 Oct;46(5):643-9
references.pmid: 10670749
references.citation: Circulation. 2003 Jul 1;107(25):3133-40
references.pmid: 12796126
references.citation: Lancet. 2004 Feb 28;363(9410):675-81
references.pmid: 15001324
references.citation: Ann Rheum Dis. 2007 Oct;66(10):1339-44
references.pmid: 17261532
references.citation: Arthritis Rheum. 2007 May;56(5):1433-9
references.pmid: 17469100
references.citation: Arthritis Res Ther. 2003;5(6):290-302
references.pmid: 14680505
references.citation: Autoimmun Rev. 2005 Mar;4(3):153-61
references.pmid: 15823501
references.citation: Ann Rheum Dis. 2005 Oct;64(10):1414-20
references.pmid: 15843454
references.citation: N Engl J Med. 2000 Nov 30;343(22):1586-93
references.pmid: 11096165
references.citation: Arthritis Rheum. 2007 Sep;56(9):2896-904
references.pmid: 17763441
references.citation: Rheumatology (Oxford). 2000 Mar;39(3):321-7
references.pmid: 10788543
references.citation: Ann Rheum Dis. 2008 Aug;67(8):1104-10
references.pmid: 17666447
references.citation: Reumatismo. 2008 Jan-Mar;60(1):41-9
references.pmid: 18432324
references.citation: Aging (Milano). 1996 Aug;8(4):277-81
references.pmid: 8904958
references.citation: Am J Epidemiol. 1980 Jan;111(1):87-98
references.pmid: 7352462
references.citation: N Engl J Med. 1999 Jan 28;340(4):253-9
references.pmid: 9920948
references.citation: Clin Infect Dis. 2004 Aug 1;39(3):295-9
references.pmid: 15306993
references.citation: Drugs Aging. 2006;23(2):167-78
references.pmid: 16536638
references.citation: Mech Ageing Dev. 1999 Feb 1;107(1):1-14
references.pmid: 10197784
references.citation: Arthritis Rheum. 2003 Jan;48(1):35-45
references.pmid: 12528101
references.citation: Arthritis Rheum. 2003 Apr;48(4):917-26
references.pmid: 12687533
references.citation: Ann Rheum Dis. 2005 Nov;64 Suppl 4:iv42-3
references.pmid: 16239385
references.citation: Ann Rheum Dis. 2007 Nov;66(11):1473-8
references.pmid: 17426065
references.citation: J Rheumatol. 2005 Jul;32(7):1213-8
references.pmid: 15996054
references.citation: Rheum Dis Clin North Am. 2000 Aug;26(3):455-73
references.pmid: 10989507
references.citation: J Immunol. 2001 Sep 15;167(6):3231-8
references.pmid: 11544310
references.citation: Rheumatology (Oxford). 2005 Dec;44(12):1546-8
references.pmid: 16263785
references.citation: Arthritis Rheum. 2004 Apr;50(4):1051-65
references.pmid: 15077287
references.citation: Rheumatol Int. 2001 Apr;20(3):85-7
references.pmid: 11354562
references.citation: Arthritis Rheum. 2004 May;50(5):1400-11
references.pmid: 15146409
references.citation: J Rheumatol. 2003 Mar;30(3):443-8
references.pmid: 12610798
references.citation: Ann Rheum Dis. 2004 Nov;63 Suppl 2:ii13-ii17
references.pmid: 15479864
references.citation: Arthritis Rheum. 2006 Aug;54(8):2368-76
references.pmid: 16868999
references.citation: Arthritis Rheum. 2002 Jun;46(6):1443-50
references.pmid: 12115173
references.citation: Best Pract Res Clin Rheumatol. 2002 Dec;16(5):707-22
references.pmid: 12473269
references.citation: Ann Intern Med. 1999 Mar 16;130(6):478-86
references.pmid: 10075615
references.citation: N Engl J Med. 1997 Jul 17;337(3):141-7
references.pmid: 9219699
references.citation: Rheumatol Int. 2003 Mar;23(2):70-4
references.pmid: 12634939
references.citation: Am J Physiol. 1992 Feb;262(2 Pt 2):R211-5
references.pmid: 1539727
references.citation: Ann N Y Acad Sci. 2006 Jun;1069:420-7
references.pmid: 16855169
references.citation: Ann Rheum Dis. 2004 Nov;63(11):1372-8
references.pmid: 15020312
references.citation: JAMA. 2006 May 17;295(19):2275-85
references.pmid: 16705109
references.citation: Arthritis Rheum. 2007 Sep;56(9):2905-12
references.pmid: 17763428
references.citation: Am Heart J. 2008 Aug;156(2):336-41
references.pmid: 18657665
references.citation: Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S93-9
references.pmid: 16273792
references.citation: Arthritis Rheum. 2007 Jun;56(6):1754-64
references.pmid: 17530704
references.citation: Clin Exp Rheumatol. 1996 Sep-Oct;14(5):537-42
references.pmid: 8913656
references.citation: Aging Cell. 2008 Dec;7(6):805-12
references.pmid: 18782346
references.citation: Arthritis Rheum. 2008 Mar;58(3):667-77
references.pmid: 18311816
references.citation: Rheumatology (Oxford). 2005 Mar;44(3):271-3
references.pmid: 15561736
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1226-9
references.pmid: 16414968
references.citation: Drugs Aging. 2007;24(3):239-54
references.pmid: 17362051
references.citation: Arthritis Rheum. 2002 Sep;46(9):2294-300
references.pmid: 12355476
references.citation: Adv Immunol. 1980;29:287-330
references.pmid: 6998260
references.citation: Arthritis Rheum. 2007 May 15;57(4):679-85
references.pmid: 17471545
references.citation: Semin Arthritis Rheum. 2005 Apr;34(5 Suppl1):19-22
references.pmid: 15852250
references.citation: J Rheumatol. 2006 Feb;33(2):234-43
references.pmid: 16465653
references.citation: Ann Rheum Dis. 2005 Oct;64(10):1421-6
references.pmid: 15829572
references.citation: Ann Rheum Dis. 2009 Jul;68(7):1136-45
references.pmid: 18753157
references.citation: Br J Rheumatol. 1986 Nov;25(4):333-41
references.pmid: 2946352
references.citation: Ann Rheum Dis. 2006 Mar;65(3):379-84
references.pmid: 16150792
references.citation: Scand J Immunol. 2004 Jul-Aug;60(1-2):199-208
references.pmid: 15238090
references.citation: Mech Ageing Dev. 1998 May 15;102(2-3):199-209
references.pmid: 9720652
references.citation: Arthritis Rheum. 2004 Jun;50(6):1740-51
references.pmid: 15188349
references.citation: Rheumatology (Oxford). 2007 Jul;46(7):1157-60
references.pmid: 17478469
references.citation: J Immunol. 1993 Jun 15;150(12):5219-30
references.pmid: 8515056
references.citation: Arthritis Rheum. 2004 Nov;50(11):3432-43
references.pmid: 15529377
references.citation: Ann Rheum Dis. 2006 Nov;65(11):1438-43
references.pmid: 16644782
references.citation: Arthritis Res Ther. 2004;6 Suppl 2:S3-S11
references.pmid: 15228615
references.citation: Rheumatology (Oxford). 2005 May;44(5):695-6
references.pmid: 15705631
references.citation: Ageing Res Rev. 2009 Jan;8(1):18-30
references.pmid: 18692159
references.citation: Ann Epidemiol. 1996 Sep;6(5):376-80
references.pmid: 8915467
references.citation: J Rheumatol. 2003 Dec;30(12):2563-71
references.pmid: 14719195
references.citation: Rheumatology (Oxford). 2005 Jun;44(6):714-20
references.pmid: 15741198
references.citation: Arthritis Rheum. 2006 Nov;54(11):3399-407
references.pmid: 17075823
references.citation: Immunity. 2006 May;24(5):495-9
references.pmid: 16713964
references.citation: Exp Gerontol. 2003 Aug;38(8):833-41
references.pmid: 12915205
references.citation: Ann Rheum Dis. 2009 Sep;68(9):1470-3
references.pmid: 19015210
references.citation: Arthritis Rheum. 2007 Apr;56(4):1125-33
references.pmid: 17393394
references.citation: Am J Med. 2004 Mar 1;116(5):305-11
references.pmid: 14984815
references.citation: Ann Rheum Dis. 2009 May;68(5):648-53
references.pmid: 18467516
references.citation: J Rheumatol. 2003 Apr;30(4):691-6
references.pmid: 12672185
references.citation: Gerontology. 2009;55(3):250-8
references.pmid: 18849599
references.citation: Rheumatology (Oxford). 2006 Dec;45(12):1555-7
references.pmid: 16690762